Clinical Trial Update: Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy [NA]

View source ↗

Summary

This trial evaluated whether ketorolac and remote ischemic preconditioning can reduce renal ischemia-reperfusion injury during partial nephrectomy in renal cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Yonsei University | Conditions: Renal Cell Carcinoma | NA | Status: COMPLETED